CELLREGEN
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

CELLREGEN Trademark

Serial Number: 88595964

CELLREGEN is a trademark filed by UNIVERSITY OF UTAH RESEARCH FOUNDATION on August 28, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

UNIVERSITY OF UTAH RESEARCH FOUNDATION (154 trademarks)

C/O DON BROWN
Salt Lake City, UT 84112

Entity Type: 19

Trademark Details

Filing Date

August 28, 2019

Registration Date

Not Registered

Published for Opposition

January 26, 2021

Goods & Services

Academic support, namely, providing clinical programs, academic conferences, training, mentoring and fellowships in the field of clinical trials, technology transfer, product development, optimization, manufacturing and commercialization; educational services in the field of cellular therapy and regenerative medicine

Contract manufacturing, namely, manufacture of cellular therapies and regenerative medicines; conducting manufacturing support, namely, development of operating procedures and batch records, cell expansion, master and working cell bank production and clinical trials in the field of cellular therapy and regenerative medicine

Biological and chemical products for use by clinicians in regenerative medicine for medical purposes, namely, cellular healing therapies and regenerative medicine

Business consulting and industry collaboration in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials, applications for drug approval and product development; providing product commercialization assistance in the field of cellular therapy and regenerative medicine; commercialization services in the field of cellular therapy and regenerative medicine

Biological preparations for others, namely, human cells and tissue for scientific and research use; Cells and biological tissue, namely, human tissue, stem cells, bone marrow, amniotic fluid and blood, for scientific research and use in cellular therapies; biological preparations for others, namely, human cells and tissue, for use in the research of treatment of degenerative diseases, wound healing, and cell therapy

Medical services in the field of cell-based therapies, including the use of biological cells and tissue in the delivery of cell-based therapies and regenerative medicine; Cell therapy services for the treatment of degenerative diseases, wounds, hematologic diseases, hematologic disorders and immuno-therapy; providing consultancy and information relating to these cell therapies for medical purposes; administration of cell therapies for the treatment of disorders, diseases, and injuries; medical services, namely, isolation of regenerative cells relating to cell therapy services, stem cell collection, processing, phenotypic characterization, infusion and storage for medical and scientific purposes; providing medical therapies, namely, stem cell therapies and therapies for regeneration of human tissues and cells; providing educational medical information about cellular therapy and regenerative medicines

Conducting clinical trials and research for others in the field of cellular therapy and regenerative medicine; providing medical and scientific research information in the field of clinical trials for cellular therapy and regenerative medicine; Product research and development; Product development consultation; Product research and development services for others in the field of cellular therapy and regenerative medicine; scientific development in the field of stem cells and regenerative medicine; scientific research, discovery, technology transfer, process development and clinical trials in the field of cellular therapy and regenerative medicine

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 25, 2021 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 25, 2021 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 23, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 26, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jan 26, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 6, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 17, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 16, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 15, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 15, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 24, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jun 24, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jun 24, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 4, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 4, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 4, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 4, 2019 GNRN
NON-FINAL ACTION E-MAILED
Dec 4, 2019 GNRT
NON-FINAL ACTION WRITTEN
Dec 4, 2019 CNRT
ASSIGNED TO EXAMINER
Dec 2, 2019 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 12, 2019 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 11, 2019 NWOS
NEW APPLICATION ENTERED
Aug 31, 2019 NWAP